WO2002018001A3 - Apparatus for treatment of chronic obstructive pulmonary disease and associated method - Google Patents

Apparatus for treatment of chronic obstructive pulmonary disease and associated method Download PDF

Info

Publication number
WO2002018001A3
WO2002018001A3 PCT/US2001/026939 US0126939W WO0218001A3 WO 2002018001 A3 WO2002018001 A3 WO 2002018001A3 US 0126939 W US0126939 W US 0126939W WO 0218001 A3 WO0218001 A3 WO 0218001A3
Authority
WO
WIPO (PCT)
Prior art keywords
opening
composition
chamber
treatment
patient
Prior art date
Application number
PCT/US2001/026939
Other languages
French (fr)
Other versions
WO2002018001A2 (en
Inventor
Robert W Addington
Robert Stephens
Stuart Miller
Original Assignee
Pneumoflex Systems L L C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pneumoflex Systems L L C filed Critical Pneumoflex Systems L L C
Priority to AU2001288503A priority Critical patent/AU2001288503B2/en
Priority to CA002420545A priority patent/CA2420545A1/en
Priority to AU8850301A priority patent/AU8850301A/en
Priority to EP01968244A priority patent/EP1313525A2/en
Priority to MXPA03001840A priority patent/MXPA03001840A/en
Publication of WO2002018001A2 publication Critical patent/WO2002018001A2/en
Publication of WO2002018001A3 publication Critical patent/WO2002018001A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0021—Mouthpieces therefor
    • A61M15/0023—Mouthpieces therefor retractable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2209/00—Ancillary equipment
    • A61M2209/06—Packaging for specific medical equipment

Abstract

An apparatus and method for treatment of a patient having a pulmonary disease involving chronic obstruction of the airways includes a container having therein a chamber containing a composition of L-tartrate in a pharmaceutically acceptable carrier; an opening connected to the chamber so as to provide an outlet thereof, the opening sized for producing droplets of a predetermined size range responsive to the composition being motivated from the chamber through the opening; and a source of motivating force connected with the chamber so as to motivate the compositions through the opening to thereby cause nebulization of the composition. A treatment kit comprises the container described and a mouthpiece connectable to the container so as to be in fluid connection with the opening and downstream therefrom to thereby convey the nebulized composition into a patient's mouth to thereby facilitate oral inhalation of the nebulized composition by the patient.
PCT/US2001/026939 2000-08-30 2001-08-30 Apparatus for treatment of chronic obstructive pulmonary disease and associated method WO2002018001A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
AU2001288503A AU2001288503B2 (en) 2000-08-30 2001-08-30 Apparatus for treatment of chronic obstructive pulmonary disease and associated method
CA002420545A CA2420545A1 (en) 2000-08-30 2001-08-30 Apparatus for treatment of chronic obstructive pulmonary disease and associated method
AU8850301A AU8850301A (en) 2000-08-30 2001-08-30 Apparatus for treatment of chronic obstructive pulmonary disease and associated method
EP01968244A EP1313525A2 (en) 2000-08-30 2001-08-30 Apparatus for treatment of chronic obstructive pulmonary disease and associated method
MXPA03001840A MXPA03001840A (en) 2000-08-30 2001-08-30 Apparatus for treatment of chronic obstructive pulmonary disease and associated method.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22906600P 2000-08-30 2000-08-30
US60/229,066 2000-08-30

Publications (2)

Publication Number Publication Date
WO2002018001A2 WO2002018001A2 (en) 2002-03-07
WO2002018001A3 true WO2002018001A3 (en) 2002-07-25

Family

ID=22859715

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/026939 WO2002018001A2 (en) 2000-08-30 2001-08-30 Apparatus for treatment of chronic obstructive pulmonary disease and associated method

Country Status (5)

Country Link
EP (1) EP1313525A2 (en)
AU (2) AU8850301A (en)
CA (1) CA2420545A1 (en)
MX (1) MXPA03001840A (en)
WO (1) WO2002018001A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009058776A1 (en) 2007-10-31 2009-05-07 Stevens Medical, Llc Nebulizer having a high efficiency impactor

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5839430A (en) * 1996-04-26 1998-11-24 Cama; Joseph Combination inhaler and peak flow rate meter
WO1999036115A2 (en) * 1998-01-16 1999-07-22 1263152 Ontario Inc. Indicating device for use with a dispensing device
WO1999049917A1 (en) * 1998-03-27 1999-10-07 Astrazeneca Ab Inhalation device
US6004268A (en) * 1998-04-21 1999-12-21 Addington; W. Robert Aspiration screening process for assessing post surgery patient's risk for pneumonia

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5839430A (en) * 1996-04-26 1998-11-24 Cama; Joseph Combination inhaler and peak flow rate meter
WO1999036115A2 (en) * 1998-01-16 1999-07-22 1263152 Ontario Inc. Indicating device for use with a dispensing device
WO1999049917A1 (en) * 1998-03-27 1999-10-07 Astrazeneca Ab Inhalation device
US6004268A (en) * 1998-04-21 1999-12-21 Addington; W. Robert Aspiration screening process for assessing post surgery patient's risk for pneumonia

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
FUJIMURA M ET AL: "SEX DIFFERENCE IN THE INHALED TARTARIC ACID COUGH THRESHOLD IN NON-ATOPIC HEALTHY SUBJECTS", THORAX, LONDON, GB, vol. 45, no. 8, August 1990 (1990-08-01), pages 633 - 634, XP002919151 *

Also Published As

Publication number Publication date
MXPA03001840A (en) 2004-11-01
CA2420545A1 (en) 2002-03-07
EP1313525A2 (en) 2003-05-28
AU2001288503B2 (en) 2007-05-17
WO2002018001A2 (en) 2002-03-07
AU8850301A (en) 2002-03-13

Similar Documents

Publication Publication Date Title
Rau et al. Performance comparison of nebulizer designs: constant-output, breath-enhanced, and dosimetric
TW200607538A (en) Medicament inhaler device
JP5086988B2 (en) Dry powder aerosolized inhaler
WO2007117675A3 (en) Healthy pleasurable inhalation device
CN102264421A (en) Method and apparatus comprising stepped mouthpiece for aerosol drug delivery
AU2002327052B2 (en) Adaptors for inhalers to improve performance
WO2004103447A3 (en) Delivery device and method
BRPI0416698A (en) nice and sound inhalation device
NZ222446A (en) Inhalation device with chamber of circular cross-section
YU56600A (en) Device for delivering an active agent to the lung of a human patient
BR0209798A (en) An inhalation device
EP1614431A3 (en) Compositions for treatment of disorders of the oesophagus
EA199901083A1 (en) INHALER FOR POWDERED MEDICINES
MXPA06013221A (en) Inhalation powder formulations containing enantiomerically pure beta-agonists.
JP2013512715A (en) Device and method comprising an adjustable stepped mouthpiece for inhalant aerosol delivery
IL170518A (en) Liquid oral dosage formulations comprising 5-methyl-2-(2'-chloro-6'-fluoroanilino) phenylacetic acid, methods for preparing them and use thereof for the manufacture of medicaments
CA2519175A1 (en) A method of treating a systemic disease
WO2004012653A3 (en) Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof
GB2437464A (en) A resonating (alerting) metered dose inhaler
WO2006014167A3 (en) Face and tracheostomy nebulizing mask
EP1224003B8 (en) Combination mouthpiece for inhalation therapy devices used by oxygen dependent patients
CN205494579U (en) Medicine device is spouted with internal medicine to tuberculosis prevention and cure
WO2002018001A3 (en) Apparatus for treatment of chronic obstructive pulmonary disease and associated method
SG137859A1 (en) Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
CN201880153U (en) Fog-storing tank

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2001288503

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2420545

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: PA/a/2003/001840

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 2001968244

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001968244

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWG Wipo information: grant in national office

Ref document number: 2001288503

Country of ref document: AU